A weight loss supplement has been given the FDA's highest recall classification after being pulled from shelves in December.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A broccoli product sold at Walmart in Michigan was under recall. Now the FDA says the product may be considered deadly.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The U.S. Food and Drug Administration has upgraded the recall for broccoli sold at Walmart stores in 20 states to its most ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...